114 related articles for article (PubMed ID: 29022647)
1. Use of metformin is associated with lower incidence of cancer in patients with type 2 diabetes.
Muszyńska-Ogłaza A; Zarzycka-Lindner G; Olejniczak H; Polaszewska-Muszyńska M; Junik R
Endokrynol Pol; 2017; 68(6):652-658. PubMed ID: 29022647
[TBL] [Abstract][Full Text] [Related]
2. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
[TBL] [Abstract][Full Text] [Related]
3. Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
Kusturica J; Kulo Ćesić A; Gušić E; Maleškić S; Rakanović-Todić M; Šečić D
Med Glas (Zenica); 2017 Aug; 14(2):176-181. PubMed ID: 28698536
[TBL] [Abstract][Full Text] [Related]
4. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.
Mary A; Hartemann A; Liabeuf S; Aubert CE; Kemel S; Salem JE; Cluzel P; Lenglet A; Massy ZA; Lalau JD; Mentaverri R; Bourron O; Kamel S
Cardiovasc Diabetol; 2017 Feb; 16(1):24. PubMed ID: 28202017
[TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
6. Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner.
Tsai MJ; Yang CJ; Kung YT; Sheu CC; Shen YT; Chang PY; Huang MS; Chiu HC
Lung Cancer; 2014 Nov; 86(2):137-43. PubMed ID: 25267165
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of metformin in patients with endometrial cancer: a retrospective study.
Seebacher V; Bergmeister B; Grimm C; Koelbl H; Reinthaller A; Polterauer S
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():291-6. PubMed ID: 27423029
[TBL] [Abstract][Full Text] [Related]
8. Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting.
Geraldine N; Marc A; Carla T; Chantal M; Stefaan B; Welcome W; Frank B
Diabetes Res Clin Pract; 2012 Aug; 97(2):331-6. PubMed ID: 22386769
[TBL] [Abstract][Full Text] [Related]
9. Metformin use and the risk of esophageal cancer in Barrett esophagus.
Agrawal S; Patel P; Agrawal A; Makhijani N; Markert R; Deidrich W
South Med J; 2014 Dec; 107(12):774-9. PubMed ID: 25502158
[TBL] [Abstract][Full Text] [Related]
10. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
11. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
12. Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus.
Hui T; Shang C; Yang L; Wang M; Li R; Song Z
Sci Rep; 2021 May; 11(1):10034. PubMed ID: 33976288
[TBL] [Abstract][Full Text] [Related]
13. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
[TBL] [Abstract][Full Text] [Related]
14. [New clinical data with metformin therapy in patients with diabetes mellitus].
Jermendy G
Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
[TBL] [Abstract][Full Text] [Related]
15. Do endometrial cancer patients benefit from metformin intake?
Lemańska A; Zaborowski M; Spaczyński M; Nowak-Markwitz E
Ginekol Pol; 2015 Jun; 86(6):419-23. PubMed ID: 26255448
[TBL] [Abstract][Full Text] [Related]
16. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
Tseng CH
Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
[TBL] [Abstract][Full Text] [Related]
17. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
[TBL] [Abstract][Full Text] [Related]
18. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
[TBL] [Abstract][Full Text] [Related]
19. Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes.
Tan BX; Yao WX; Ge J; Peng XC; Du XB; Zhang R; Yao B; Xie K; Li LH; Dong H; Gao F; Zhao F; Hou JM; Su JM; Liu JY
Cancer; 2011 Nov; 117(22):5103-11. PubMed ID: 21523768
[TBL] [Abstract][Full Text] [Related]
20. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
